Cvirn G, Gallistl S, Muntean W
Department of Pediatrics and Ludwig Boltzmann Research Institute for Pediatric Hemostasis and Thrombosis, University of Graz, Austria.
Thromb Res. 1999 Feb 15;93(4):183-90. doi: 10.1016/s0049-3848(98)00181-9.
It has been suggested that antithrombin (AT) and protein C (PC) might be less important in newborn plasma than in adult plasma for the inhibition of clotting activation. To assess the importance of AT and PC for the regulation of thrombin generation in newborn as compared with adult plasma, thrombin generation was determined in the presence of different concentrations of AT and PC. In both, newborn and adult plasmas, reduction of AT and PC resulted in an increase of thrombin generation after intrinsic activation. On the other hand, supplementation of AT and PC decreased thrombin generation in a dose-dependent manner. Clotting times were influenced by different PC concentrations, whereas clotting times were almost not affected by different amounts of AT. Our study suggests that the significance of AT and PC in the regulation of thrombin generation is the same in newborn and adult plasma. Our experimental results also support the notion that administration of AT or protein C concentrates may be beneficial in some clinical situations leading to an increased clotting activation in newborns.
有人提出,对于抑制凝血激活而言,抗凝血酶(AT)和蛋白C(PC)在新生儿血浆中可能不如在成人血浆中重要。为了评估与成人血浆相比,AT和PC对新生儿凝血酶生成调节的重要性,在不同浓度的AT和PC存在的情况下测定了凝血酶生成。在新生儿和成人血浆中,AT和PC的减少都会导致内源性激活后凝血酶生成增加。另一方面,补充AT和PC会以剂量依赖的方式降低凝血酶生成。凝血时间受不同PC浓度的影响,而凝血时间几乎不受不同量AT的影响。我们的研究表明,AT和PC在调节凝血酶生成中的重要性在新生儿和成人血浆中是相同的。我们的实验结果也支持这样一种观点,即在某些导致新生儿凝血激活增加的临床情况下,给予AT或蛋白C浓缩物可能是有益的。